Galena Biopharma intends to price public sale of common-share units

Company will sell shares with warrants through bookrunner Oppenheimer

By Devika Patel

Knoxville, Tenn., Sept. 12 - Galena Biopharma, Inc. said it plans to price a public offering of units.

The units consist of common shares and warrants.

Oppenheimer & Co. Inc. is the bookrunning manager.

Galena is a biotechnology company based in Lake Oswego, Ore.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.